George Golumbeski, Director at Acumen Pharmaceuticals, holds 35.50K shares in Acumen Pharmaceuticals (Ticker: ABOS), holds 0.00 shares in SAGE Therapeutics (Ticker: SAGE), holds 54.61K shares in Shattuck Labs (Ticker: STTK).
George Golumbeski latest transaction was an Uninformative Buy of ―.
What was George Golumbeski's most profitable transaction?
George Golumbeski’s most profitable transaction was an Informative Buy of SAGE stock on May 9, 2022. The return on the trade was 84.00%.
What is George Golumbeski's role in Acumen Pharmaceuticals?
George Golumbeski's role in Acumen Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.